New Diagnostic Strategies for Detection of Helicobacter pylori Infection in Pediatric Patients.
Helicobacter pylori (H pylori) is a common chronic bacterial infection that is an important cause of peptic ulcer disease and gastroduodenal disease in children. H pylori is also associated with extragastric manifestations, including growth reduction, iron-deficiency anemia, and idiopathic thrombocytopenic purpura. Current guidelines recommend endoscopy with biopsy for the definitive demonstration of H pylori infection. In contrast to serology, the fecal antigen test and the urea breath test provide reliable, sensitive, and specific results for detecting active H pylori infection in children before and after treatment. The first-line treatment option for pediatric patients is triple therapy with a proton pump inhibitor and 2 antibiotics, which include amoxicillin and clarithromycin or metronidazole. Decreasing eradication rates and the emergence of antibiotic-resistant strains of H pylori have led to the use of other treatments, such as sequential therapy or triple therapy with newer antibiotics, particularly in geographic areas with high rates of antibiotic resistance. Patients should be tested after treatment to confirm eradication, as the absence of symptoms does not necessarily mean that H pylori is no longer present. This clinical roundtable monograph provides an overview of H pylori infection, as well as expert insight into the diagnosis and management of H pylori infection in children.
GI Care for Kids, LLC Children's Center for Digestive Healthcare LLC Atlanta, Georgia.
Benjamin D
BD
Gold
Pediatrician-in-Chief Children's Hospital of San Antonio San Antonio, Texas Professor & Vice Chair Department of Pediatrics Baylor College of Medicine Houston, Texas.
Mark A
MA
Gilger
Professor and Chair Department of Pediatrics University of Maryland School of Medicine Physician-in-Chief University of Maryland Children's Hospital Baltimore, Maryland.
Steven J
SJ
Czinn